Articles from Levi & Korsinsky, LLP

IMPORTANT DATE: September 4, 2026. Investors who wish to seek appointment as lead plaintiff in the Photronics, Inc. (NASDAQ: PLAB) securities class action must file a motion by this date. Start your claim now before the deadline or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

"We are reaffirming 2026 full year guidance for all financial measures." That was the promise Verra Mobility Corporation (NASDAQ: VRRM) made to shareholders on May 6, 2026. Twenty days later, the Company slashed that guidance by $35 million at the midpoint after disclosing that Avis Budget Group had terminated a contract representing over 10% of total revenue. Shares collapsed 71%, erasing $9.23 per share in value.

Levi & Korsinsky, LLP highlights the contrast between GeneDx Holdings Corp.'s (NASDAQ: WGS) promises to investors and the actual results of its Fabric Genomics acquisition. Shareholders who purchased WGS securities between April 16, 2025 and May 4, 2026 and suffered losses may be entitled to compensation. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP encourages investors who suffered losses in Grail, Inc. (NASDAQ: GRAL) to contact the firm. Those who purchased GRAL securities between May 13, 2025 and February 19, 2026 may be entitled to recover damages. Find out if you are eligible to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP examines the adequacy of PicS N.V.'s (Nasdaq: PICS) risk disclosures in connection with its January 30, 2026 initial public offering. A securities class action has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Class A common stock in or traceable to the IPO. Find out if your losses qualify for recovery. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP notifies investors that Eric Benjamin, Insulet Corporation's (NASDAQ: PODD) former Executive Vice President and Chief Operating Officer, is named as a defendant in a securities class action alleging he made false statements about Omnipod product safety while selling $3.7 million in company stock during the Class Period. Find out if you can recover losses tied to executive misconduct. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in Via Transportation, Inc. (NYSE: VIA) that a securities class action has been filed on behalf of shareholders who purchased shares in or traceable to the Company's September 2025 initial public offering. Check if you can recover your investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP encourages investors who suffered losses in ADMA Biologics, Inc. (NASDAQ: ADMA) to contact the firm. Those who purchased ADMA securities between August 9, 2024 and March 25, 2026 may be entitled to recover damages. Find out if you are eligible to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Erasca, Inc. (NASDAQ: ERAS) during the period from January 14, 2025 through April 26, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Hub Group, Inc. (NASDAQ: HUBG) during the period from April 28, 2023, through May 11, 2026, may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP notifies investors that Chen Fang, BitGo Holdings, Inc.'s (NYSE: BTGO) Chief Revenue Officer and Director, is named as an individual defendant in a securities class action filed on behalf of shareholders who purchased BitGo securities between January 22, 2025 and May 13, 2026. Find out if you are eligible to recover your investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Shareholders who held ARS Pharmaceuticals (NASDAQ: SPRY) stock watched the value drop more than 23% in after-hours trading on June 24, 2026, after the Company disclosed that Neffy® received no new commercial formulary additions or payer-coverage decisions in the July 1, 2026 review cycle. Investors who lost money on SPRY are encouraged to submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Shareholders who held Gildan Activewear (NYSE: GIL) lost nearly 19% of their investment value today after Jehoshaphat Research published allegations that Gildan had been stuffing distributor channels with approximately $510 million in excess inventory, a condition never referenced in the Company's forward guidance or outlook statements. Those who lost money on GIL are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP highlights the contrast between Nano-X Imaging Ltd.'s (NASDAQ: NNOX) public commitments and its actual results. A securities class action has been filed on behalf of investors who purchased NNOX securities between March 31, 2025 and April 17, 2026. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Neumora Therapeutics (NASDAQ: NMRA) shareholders watched their investment collapse today after the company disclosed that navacaprant failed both Phase 3 KOASTAL-2 and KOASTAL-3 trials in major depressive disorder and announced an immediate workforce reduction of approximately 35%. Investors who lost money on NMRA are encouraged to submit their information now to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP encourages investors who suffered losses in Microsoft Corporation (NASDAQ: MSFT) to contact the firm. WHO IS AFFECTED: Those who purchased MSFT securities between May 1, 2025 and January 28, 2026 may be entitled to recover damages. Find out if you are eligible to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP examines the adequacy of Commvault Systems, Inc.'s (NASDAQ: CVLT) risk disclosures during the period from April 29, 2025 through January 26, 2026. A securities class action has been filed in the United States District Court for the District of New Jersey on behalf of stockholders who suffered losses. Find out if you qualify to recover your investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in Sportradar Group AG (NASDAQ: SRAD) that two senior executives are named as individual defendants in a securities class action covering purchases between November 7, 2024, and April 21, 2026. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Shareholders who held Oxford Industries, Inc. (NYSE: OXM) stock lost approximately 17% of their investment value when the company slashed its FY 2026 revenue guidance midpoint to $1.49 billion and projected Q2 sales roughly 5.8% below Wall Street consensus estimates. Those who lost money on OXM are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Shares of The Ensign Group (NASDAQ: ENSG) dropped sharply on June 8, 2026, after Hunterbrook Media published a short-seller report alleging systemic neglect, quality-measure gaming, and improper related-party billing across the company's skilled nursing facilities. Shareholders who lost money on ENSG are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

SailPoint, Inc. (NASDAQ: SAIL) lost roughly 12% of its market value today following the Company’s Q1 2027 earnings release and forward guidance. The decline reduced the company's market capitalization significantly and reflected investor reaction to management's outlook for future performance. Shareholders who suffered losses on their SAIL investment are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP highlights the contrast between GeneDx Holdings Corp.'s (NASDAQ: WGS) promises to investors and the actual results of its Fabric Genomics acquisition. Shareholders who purchased WGS securities between April 16, 2025 and May 4, 2026 and suffered losses may be entitled to compensation. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP notifies investors in Phreesia, Inc. (NYSE: PHR) that a class action has been filed on behalf of shareholders who purchased securities between May 8, 2025 and March 30, 2026. Find out if you qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

From a February 2025 earnings call where management assured analysts that inventory levels would "wash through pretty quickly" and the business model was delivering "strong and steady margins," Wall Street coverage of Graphic Packaging Holding Company (NYSE: GPK) underwent a dramatic reassessment over the following twelve months. Investors who purchased GPK securities between February 4, 2025 and February 2, 2026 and suffered losses may be entitled to compensation.

Shake Shack (NYSE: SHAK) lost approximately 9-10% of its value today after the company cut FY 2026 restaurant-level profit margin guidance from 23-23.5% to 22-23% and trimmed quarterly guidance from 24-24.5% to only 22-23%. Shareholders who lost money on SHAK are encouraged to submit their information immediately. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Shareholders of Oculis Holding AG (NASDAQ: OCS) lost nearly $7 per share, more than 23%, in a single trading session when the company disclosed that its Phase 3 DIAMOND-1 and DIAMOND-2 trials for OCS-01 failed to meet the primary endpoint -- mean change in best-corrected visual acuity at week 52 -- in diabetic macular edema. Oculis simultaneously announced it would not pursue an FDA filing for the DME indication. Investors who lost money on OCS are encouraged to submit their information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in POET Technologies Inc. (NASDAQ: POET) of a pending securities class action. Class Period: April 1, 2026 through April 27, 2026. Check if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Levi & Korsinsky, LLP encourages investors who suffered losses in Regencell Bioscience Holdings Limited (NASDAQ: RGC) to contact the firm. Those who purchased RGC securities between October 28, 2024 and October 31, 2025 may be entitled to recover damages. Find out if you qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in FS KKR Capital Corp. (NYSE: FSK) that two senior executives are named as individual defendants in a securities class action covering purchases between May 8, 2024 and February 25, 2026. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Levi & Korsinsky, LLP notifies investors that Stephan Winckels, Chief Medical Officer of Immutep Limited (NASDAQ: IMMP), is named as an individual defendant in a securities class action filed on behalf of shareholders who purchased ADRs between March 24, 2025 and March 12, 2026. Find out if you qualify to recover losses from the IMMP class action. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP encourages investors who suffered losses in Globant S.A. (NYSE: GLOB) to contact the firm. Those who purchased GLOB securities between February 15, 2024 and August 14, 2025 may be entitled to recover damages. Find out if you are eligible to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP tracks Wall Street analyst opinion on AeroVironment, Inc. (NASDAQ: AVAV) following a securities class action filed on behalf of investors who purchased AVAV securities between June 25, 2025 and March 10, 2026. Find out if you qualify to recover losses from AVAV's decline or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP examines the adequacy of SES AI Corporation's (NYSE: SES) risk disclosures during the Class Period of January 29, 2025 through March 4, 2026. A securities class action has been filed on behalf of investors who suffered losses. Find out if you qualify to recover losses from inadequate disclosures. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Shareholders who held Photronics (NASDAQ: PLAB) stock lost more than 30% of their investment today after the Company reported fiscal Q2 results that fell below its own guidance. Those who purchased PLAB shares and suffered a loss are encouraged to submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Regeneron Pharmaceuticals (NASDAQ: REGN) shares dropped sharply after the Company disclosed on May 16, 2026, that its Phase 3 trial of fianlimab plus Libtayo in first-line metastatic melanoma failed to meet its primary endpoint versus Merck's Keytruda. Shareholders who lost money on REGN are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Shareholders who lost money on Prestige Consumer Healthcare (NYSE: PBH) stock following the Company's Q4 FY 2026 earnings miss are encouraged to submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Shareholders who held TriSalus Life Sciences Inc. (TLSI) stock lost money after the company cut its full-year 2026 revenue guidance to $54 million-$57 million, down from the $60 million-$62 million range reaffirmed approximately two months earlier on March 5, 2026. Those who purchased TLSI shares and suffered losses are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP reminds purchasers of LKQ Corporation (NASDAQ: LKQ) securities of a pending securities class action.

Biogen Inc. (NASDAQ: BIIB) shareholders lost approximately 6.4% of their investment value on May 14, 2026, when the company disclosed that its Phase 2 "CELIA" trial for Alzheimer's candidate diranersen (BIIB080) failed to meet its primary dose-response endpoint. Investors who lost money on BIIB are encouraged to submit their information for a free evaluation. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP encourages investors who suffered losses in United Homes Group, Inc. (NASDAQ: UHG) to contact the firm.

Levi & Korsinsky, LLP provides context on investor sentiment surrounding Upstart Holdings, Inc. (NASDAQ: UPST) and a pending securities class action covering purchases between May 14, 2025 and November 4, 2025. Find out if you can recover your Upstart investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in Medpace Holdings Inc. (NASDAQ: MEDP) of a pending securities class action naming senior executives as individual defendants. Class Period: April 22, 2025 through February 9, 2026. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Levi & Korsinsky, LLP announces that a securities class action has been filed against Babcock & Wilcox Enterprises, Inc. (NYSE: BW).

Levi & Korsinsky, LLP encourages investors who suffered losses in Stellantis N.V. (NYSE: STLA) to contact the firm. WHO IS AFFECTED: Those who purchased STLA securities between February 26, 2025 and February 5, 2026 may be entitled to recover damages. Find out if you are eligible to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP highlights the contrast between Globant S.A.'s (NYSE: GLOB) promises to investors and the reality that emerged across three corrective disclosures. Shareholders who purchased GLOB securities between February 15, 2024 and August 14, 2025 and suffered losses may be entitled to compensation. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

SES AI Corporation promised investors a pipeline of transformative deals and rapid commercialization. The reality, according to a securities class action, was phantom partnerships with entities operating from residential homes and undeveloped land, circular revenue schemes, and 2026 guidance that missed Wall Street expectations by nearly $20 million.

Levi & Korsinsky, LLP alerts investors in New Era Energy & Digital, Inc. (NASDAQ: NUAI) of a pending securities class action. Class Period: November 6, 2024 through December 29, 2025. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Institutional investors holding positions in Regencell Bioscience Holdings Limited (NASDAQ: RGC) during the period October 28, 2024 through October 31, 2025 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Pinterest, Inc. (NYSE: PINS) during the period from February 7, 2025 through February 12, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP examines the adequacy of Vital Farms, Inc.'s (NASDAQ: VITL) risk disclosures in connection with a securities class action filed on behalf of shareholders who purchased securities between May 8, 2025 and February 26, 2026. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP announces that a securities class action has been filed against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX).

"Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections," stated Joseph E. Levi, Esq., managing partner of Levi & Korsinsky, LLP.

Wolfpack Research's March 12, 2026 short report did what months of Company press releases failed to do: it told the market the truth about who was really behind B&W's $2.4 billion contract. Within hours, Babcock & Wilcox Enterprises, Inc. (NYSE: BW) shares lost $1.71, closing at $13.05.

Levi & Korsinsky, LLP notifies investors that Michael Alferi, Head of Finance, principal financial officer, and principal accounting officer of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), is named as an individual defendant in a securities class action covering purchases between November 3, 2023 and March 16, 2026. Find out if you can recover losses tied to this executive's alleged misconduct. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in Pinterest, Inc. (NYSE: PINS) of a pending securities class action naming CEO William Ready and CFO Julia Brau Donnelly as individual defendants under Section 20(a) of the Securities Exchange Act of 1934.

Institutional investors holding positions in New Era Energy & Digital, Inc. (NASDAQ: NUAI) during the period from November 6, 2024 through December 29, 2025 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP notifies investors that Jesse J. Geiger, President of Medpace Holdings Inc. (NASDAQ: MEDP), is named as a defendant in a securities class action covering purchases between April 22, 2025 and February 9, 2026. Find out if you qualify to recover losses from the MEDP securities action. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

"We firmly believe that we have accomplished this patient selection goal." That was the promise. The reality: a Phase 3 trial that failed its primary endpoint, and shareholders who lost over 80% of their investment in a single trading session.

"Positive" net revenue growth. "Mid-single digit" adjusted operating income margins. "Positive" industrial free cash flows. Those were the benchmarks Stellantis N.V. (NYSE: STLA) set for fiscal 2025 on February 26, 2025. Less than twelve months later, the Company disclosed €22 billion in charges, a net loss of €2.3 billion for the first half alone, and a fundamental "reset" of its business model. Levi & Korsinsky, LLP highlights the contrast between Stellantis' promises and its actual results for shareholders who purchased STLA securities between February 26, 2025, and February 5, 2026. Find out if you qualify to recover losses from the STLA performance gap or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in United Homes Group, Inc. (NASDAQ: UHG) during the period May 19, 2025 through February 22, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or call (212) 363-7500.

On February 5, 2026, Evercore ISI slashed its price target on Gemini Space Station, Inc. (NASDAQ: GEMI) by 50%, from $15.00 to $10.00, and downgraded the stock from outperform to in line. Within two weeks, Truist Securities cut its target 46%, Needham & Co. cut 57%, and Rosenblatt cut 55%. Find out if you qualify to recover losses from GEMI's decline. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in New Era Energy & Digital, Inc. (NASDAQ: NUAI) during the period from November 6, 2024 through December 29, 2025 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or call (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in Lufax Holding Ltd (NYSE: LU) of a pending securities class action naming two senior officers as individual defendants. Class Period: April 7, 2023 through January 26, 2025. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Institutional investors holding positions in Hercules Capital, Inc. (NYSE: HTGC) during the period from May 1, 2025 through February 27, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Concorde International Group, Ltd. (NASDAQ: CIGL) during the Class Period of April 21, 2025, through July 14, 2025, may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

"We firmly believe that we have accomplished this patient selection goal." That was the promise. The reality: a Phase 3 trial that failed its primary endpoint, and shareholders who lost over 80% of their investment in a single trading session.

Levi & Korsinsky, LLP alerts investors in Pinterest, Inc. (NYSE: PINS) of a pending securities class action naming CEO William Ready and CFO Julia Brau Donnelly as individual defendants under Section 20(a) of the Securities Exchange Act of 1934.

Levi & Korsinsky, LLP alerts investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of a pending securities class action. Class Period: March 26, 2025 through November 4, 2025. Check if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

Institutional investors holding positions in ImmunityBio, Inc. (NASDAQ: IBRX) during the period January 19, 2026 through March 24, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Shares lost $1.98 per share, a 21% decline, after an FDA Warning Letter exposed allegedly false promotional claims about the Company's lead drug, ANKTIVA. Request an institutional investor loss assessment or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP notifies investors that Jeremy J. Heaton, former Chief Financial Officer of Alight, Inc. (NYSE: ALIT), is named as an individual defendant in a securities class action filed in the United States District Court for the Northern District of Illinois. The action covers purchases between November 12, 2024 and February 18, 2026. Find out if you are entitled to recover investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

From a Class Period high of $85.75 on March 2, 2026, Power Solutions International, Inc. (NASDAQ: PSIX) shares collapsed to $60.91, a decline of $24.84 per share, or nearly 29%, in a single trading session on unusually heavy volume. Levi & Korsinsky, LLP notifies investors who purchased PSIX securities between May 8, 2025 and March 2, 2026 that a securities class action has been filed. Find out if you qualify to recover your per-share losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

The artificial intelligence server market attracted tens of billions in capital as investors poured into companies powering next-generation AI infrastructure. Super Micro Computer, Inc. (NASDAQ: SMCI) rode this wave to nearly $15 billion in fiscal 2024 revenue and $22 billion in fiscal 2025, but a federal indictment now alleges approximately $2.5 billion of those sales were illegal. Levi & Korsinsky, LLP notifies investors in Super Micro Computer, Inc. (NASDAQ: SMCI) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between April 30, 2024 and March 19, 2026. Find out if you qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

"At least $775 million." That was Vital Farms' final revenue promise to shareholders for fiscal year 2025. The actual result: $759.4 million, a shortfall of more than $15.5 million. Levi & Korsinsky, LLP notifies investors in Vital Farms, Inc. (NASDAQ: VITL) that a securities class action has been filed on behalf of purchasers who acquired shares between May 8, 2025 and February 26, 2026. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Coty Inc. (NYSE: COTY) during the period November 5, 2025 through February 4, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Grocery Outlet Holding Corp. (NASDAQ: GO) during the period between August 5, 2025 and March 4, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or call (212) 363-7500.